Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
8.88
+0.93 (11.70%)
At close: May 18, 2026, 4:00 PM EDT
8.83
-0.05 (-0.56%)
Pre-market: May 19, 2026, 5:45 AM EDT
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $37.19 million as of May 19, 2026. Its market cap has decreased by -79.98% in one year.
Market Cap
37.19M
Enterprise Value
45.97M
1-Year Change
-79.98%
Ranking
Category
Stock Price
$8.88
Market Cap Chart
Since January 5, 2022, Tevogen Bio Holdings's market cap has decreased from $446.69M to $37.19M, a decrease of -91.68%. That is a compound annual growth rate of -43.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 37.19M | -43.48% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 40.91M |
| Plus Therapeutics | 40.07M |
| Lite Strategy | 39.82M |
| INmune Bio | 39.61M |
| Quantum BioPharma | 39.31M |
| Mereo BioPharma Group | 37.89M |
| Tvardi Therapeutics | 37.53M |
| Actinium Pharmaceuticals | 36.48M |